WAVE LIFE SCIENCES LTD. Adjustments to Additional Paid in Capital, Warrant Issued
WAVE LIFE SCIENCES LTD. (WVE) reported Adjustments to Additional Paid in Capital, Warrant Issued of $46.94 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-02-26
- WAVE LIFE SCIENCES LTD. adjustments to additional paid in capital, warrant issued for the quarter ending 2022-06-30 was $14.27M.
- WAVE LIFE SCIENCES LTD. adjustments to additional paid in capital, warrant issued for fiscal 2025 was $46.94M, a 233.46% increase from fiscal 2024.
- WAVE LIFE SCIENCES LTD. adjustments to additional paid in capital, warrant issued for fiscal 2024 was $14.08M.
- WAVE LIFE SCIENCES LTD. adjustments to additional paid in capital, warrant issued for fiscal 2022 was $14.27M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|
| 2025-12-31 | $46.94M 10-K · filed 2026-02-26 | |
| 2024-12-31 | $14.08M 10-K · filed 2026-02-26 | |
| 2022-12-31 | $14.27M 10-K · filed 2025-03-04 | |
| 2022-06-30 | $14.27M 10-Q · filed 2023-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |